ARTGX | FMDRX | ARTGX / FMDRX | |
Total Expense Ratio | 1.28 | 0.88 | 145% |
Annual Report Gross Expense Ratio | 1.28 | 0.88 | 145% |
Fund Existence | 18 years | 12 years | - |
Gain YTD | 24.160 | 17.881 | 135% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.75B | 9.39B | 29% |
Annual Yield % from dividends | 0.86 | 1.89 | 45% |
Returns for 1 year | 17.87 | 5.47 | 327% |
Returns for 3 years | 62.30 | 22.33 | 279% |
Returns for 5 years | 71.31 | 40.68 | 175% |
Returns for 10 years | 97.49 | 15.76 | 619% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EMSLX | 21.00 | 0.20 | +0.96% |
Shelton Emerging Markets Investor | |||
TIGRX | 16.48 | -0.01 | -0.06% |
Nuveen Core Equity R6 | |||
CLVRX | 35.67 | -0.21 | -0.59% |
Calvert US Large Cap Value Rspnb Idx R6 | |||
DCFGX | 36.50 | -0.23 | -0.63% |
Dunham Focused Large Cap Growth C | |||
BPSIX | 28.31 | -0.24 | -0.84% |
Boston Partners Small Cap Value II I |